El-Khoury, Renee
El-Khoury, Renee was paid $0.00 by Medicaid between Nov 2022 and Dec 2024, across 66 billing codes. Its largest line is 80048, Basic metabolic panel (calcium, ionized) — 0% of everything it billed.
33Billing provider infoEL-KHOURY, RENEE
TORRANCE, CA 90502
TORRANCE, CA 90502
33aNPI1881181691assigned 04/17/2018
33bProvider typeStudent in an Organized Health Care Education/Training Program
28Total paid$0.00
24GClaims25,610
24DCodes billed66
24AFirst – last monthNov 2022 – Dec 2024
Compared with peers
Next to other Student in an Organized Health Care Education/Training Program providers in California
Rank by total paid#248 of 315
Median peer was paid$3K
This provider vs. median0.0×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2022 | 1,149 | $0.00 | |
| 2023 | 11,068 | $0.00 | |
| 2024incomplete | 13,393 | $0.00 |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 80048 | Basic metabolic panel (calcium, ionized) | 0% | 154 | 152 | $0.00 |
| 83735 | 0% | 365 | 343 | $0.00 | |
| 82043 | 0% | 287 | 279 | $0.00 | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | 0% | 716 | 713 | $0.00 |
| 3075F | 0% | 216 | 207 | $0.00 | |
| 86706 | 0% | 303 | 303 | $0.00 | |
| 83036 | Hemoglobin; glycosylated (A1C) | 0% | 1,531 | 1,518 | $0.00 |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 0% | 871 | 857 | $0.00 |
| 80053 | Comprehensive metabolic panel | 0% | 1,916 | 1,692 | $0.00 |
| 90686 | 0% | 95 | 95 | $0.00 | |
| 87522 | Neg quan hep c or qual rna | 0% | 453 | 452 | $0.00 |
| 82746 | 0% | 257 | 255 | $0.00 |
54 more codes
| 36415 | Collection of venous blood by venipuncture | 0% | 3,228 | $0.00 |
| 81001 | 0% | 180 | $0.00 | |
| 86780 | 0% | 345 | $0.00 | |
| 3044F | 0% | 389 | $0.00 | |
| 99441 | 0% | 77 | $0.00 | |
| 87340 | 0% | 300 | $0.00 | |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 0% | 1,369 | $0.00 |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | 0% | 669 | $0.00 |
| 83550 | 0% | 83 | $0.00 | |
| 1220F | 0% | 595 | $0.00 | |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | 0% | 63 | $0.00 |
| 82607 | 0% | 440 | $0.00 | |
| 3074F | 0% | 888 | $0.00 | |
| 85027 | 0% | 442 | $0.00 | |
| 99205 | Prolong outpt/office vis | 0% | 80 | $0.00 |
| 82728 | 0% | 110 | $0.00 | |
| 99214 | Doctor's office visit, returning patient (more involved) | 0% | 612 | $0.00 |
| 1111F | 0% | 337 | $0.00 | |
| 87086 | Culture, bacterial; quantitative colony count, urine | 0% | 95 | $0.00 |
| 84443 | Thyroid stimulating hormone (TSH) | 0% | 123 | $0.00 |
| 3079F | 0% | 148 | $0.00 | |
| 90656 | 0% | 75 | $0.00 | |
| 4450F | 0% | 45 | $0.00 | |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | 0% | 15 | $0.00 |
| 90739 | 0% | 12 | $0.00 | |
| 85652 | 0% | 13 | $0.00 | |
| 99386 | 0% | 15 | $0.00 | |
| 99385 | 0% | 12 | $0.00 | |
| 86140 | 0% | 14 | $0.00 | |
| 82274 | 0% | 295 | $0.00 | |
| 3078F | 0% | 1,077 | $0.00 | |
| 86703 | 0% | 466 | $0.00 | |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | 0% | 1,064 | $0.00 |
| 82540 | 0% | 287 | $0.00 | |
| 80061 | Lipid panel | 0% | 1,330 | $0.00 |
| 99442 | 0% | 468 | $0.00 | |
| 99215 | Doctor's office visit, returning patient (complex) | 0% | 1,584 | $0.00 |
| 84439 | 0% | 40 | $0.00 | |
| 77067 | Screening mammography, bilateral, including computer-aided detection | 0% | 55 | $0.00 |
| 81003 | 0% | 47 | $0.00 | |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | 0% | 252 | $0.00 |
| 83540 | 0% | 101 | $0.00 | |
| 85610 | 0% | 77 | $0.00 | |
| 99396 | Periodic comprehensive preventive medicine reevaluation, established patient, 40-64 years | 0% | 25 | $0.00 |
| 3077F | 0% | 166 | $0.00 | |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | 0% | 141 | $0.00 |
| 2021F | 0% | 12 | $0.00 | |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | 0% | 63 | $0.00 |
| 90472 | Immunization administration, each additional vaccine (list separately) | 0% | 13 | $0.00 |
| 90750 | 0% | 41 | $0.00 | |
| 84100 | 0% | 28 | $0.00 | |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | 0% | 13 | $0.00 |
| 3051F | 0% | 12 | $0.00 | |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 0% | 15 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.